Abstract
The International Space Station Assembly has already been finished after adding the final research facilities in the first half of this decade. Although integration was the primary goal of its first 11 years of operation, ISS early life science research returns have grown steadily. To date, the early utilization of the ISS has spawned nearly 200 experiments in the life sciences disciplines for international and US partner research. This paper, with a specific focus on life sciences research, summarizes the scientific achievements of early research on board the ISS- both applied human research for exploration and research on the effects of microgravity on living. These accomplishments vary from recognizing improved virulence of various bacteria through spaceflight which will assist in vaccine development, new methods of distributing medication to cancer cells, and potential development for treatment of debilitating diseases like muscular dystrophy through Duchenne. The paper also look forward to full life science research capability as ISS deployment is complete in early part of this decade.
Original language | English |
---|---|
Pages (from-to) | 1398-1402 |
Number of pages | 5 |
Journal | Journal of Critical Reviews |
Volume | 7 |
Issue number | 7 |
DOIs | |
State | Published - 1 Jan 2020 |
Externally published | Yes |
Keywords
- Disease
- Medication
- Research
- Scientific
- Space Station
ASJC Scopus subject areas
- General Biochemistry, Genetics and Molecular Biology
- Pharmacology, Toxicology and Pharmaceutics (all)